Search research articles
Contact Us
Filters
Showing results (351-360 of 527) with videos related to
Page
of 53
Sort By:
Journal of Psychiatric Practice
|
July 24, 2009
Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine
David C Henderson, Xiaoduo Fan, Bikash Sharma, et al.
Circulation. Genomic and Precision Medicine
|
November 23, 2019
Portfolio Analysis of Research Grants in Data Science Funded by the National Heart, Lung, and Blood Institute
Huiqing Li, Marissa Miller, Catherine Burke, et al.
Archives of Internal Medicine
|
July 15, 2009
Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study
Kaycee M Sink, Xiaoyan Leng, Jeff Williamson, et al.
Archives of Internal Medicine
|
November 25, 1998
Knowledge of heart attack symptoms in a population survey in the United States: The REACT Trial. Rapid Early Action for Coronary Treatment
D C Goff, D E Sellers, P G McGovern, et al.
Journal of Psychiatric Research
|
August 12, 2009
Reduced overnight consolidation of procedural learning in chronic medicated schizophrenia is related to specific sleep stages
Dara S Manoach, Katharine N Thakkar, Eva Stroynowski, et al.
American Journal of Public Health
|
February 17, 2017
Cumulative Lifetime Marijuana Use and Incident Cardiovascular Disease in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
Jared P Reis, Reto Auer, Michael P Bancks, et al.
American Heart Journal
|
October 8, 2005
Enhancing quality of heart failure care in managed Medicare and Medicaid in North Carolina: results of the North Carolina Achieving Cardiac Excellence (NC ACE) Project
David C Goff, Mark W Massing, Alain G Bertoni, et al.
Psychopharmacology
|
October 27, 2004
A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients
Donald C Goff, Lawrence Herz, Thomas Posever, et al.
Plos One
|
April 16, 2015
Neural correlates of the preserved inhibition of return in schizophrenia
Yingying Tang, Yan Li, Kaiming Zhuo, et al.
Acta Psychiatrica Scandinavica
|
February 3, 2009
A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia
D C Henderson, X Fan, B Sharma, et al.
Page
of 53
Search research articles
Search
Showing results (351-360 of 527) with videos related to
Sort By:
Page
of 53
Journal of Psychiatric Practice
|
July 24, 2009
Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine
David C Henderson, Xiaoduo Fan, Bikash Sharma, et al.
Circulation. Genomic and Precision Medicine
|
November 23, 2019
Portfolio Analysis of Research Grants in Data Science Funded by the National Heart, Lung, and Blood Institute
Huiqing Li, Marissa Miller, Catherine Burke, et al.
Archives of Internal Medicine
|
July 15, 2009
Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study
Kaycee M Sink, Xiaoyan Leng, Jeff Williamson, et al.
Archives of Internal Medicine
|
November 25, 1998
Knowledge of heart attack symptoms in a population survey in the United States: The REACT Trial. Rapid Early Action for Coronary Treatment
D C Goff, D E Sellers, P G McGovern, et al.
Journal of Psychiatric Research
|
August 12, 2009
Reduced overnight consolidation of procedural learning in chronic medicated schizophrenia is related to specific sleep stages
Dara S Manoach, Katharine N Thakkar, Eva Stroynowski, et al.
American Journal of Public Health
|
February 17, 2017
Cumulative Lifetime Marijuana Use and Incident Cardiovascular Disease in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
Jared P Reis, Reto Auer, Michael P Bancks, et al.
American Heart Journal
|
October 8, 2005
Enhancing quality of heart failure care in managed Medicare and Medicaid in North Carolina: results of the North Carolina Achieving Cardiac Excellence (NC ACE) Project
David C Goff, Mark W Massing, Alain G Bertoni, et al.
Psychopharmacology
|
October 27, 2004
A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients
Donald C Goff, Lawrence Herz, Thomas Posever, et al.
Plos One
|
April 16, 2015
Neural correlates of the preserved inhibition of return in schizophrenia
Yingying Tang, Yan Li, Kaiming Zhuo, et al.
Acta Psychiatrica Scandinavica
|
February 3, 2009
A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia
D C Henderson, X Fan, B Sharma, et al.
Page
of 53